IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism

J Immunol. 1991 Jun 1;146(11):3971-6.

Abstract

Primary cultures of BALB/cJ hepatocytes treated with 10(3) U/ml rIFN-gamma consistently inhibited intracellular Plasmodium berghei liver schizont development by 50 to 70%. Monomethyl-L-arginine (NGMMLA), the competitive inhibitor of L-arginine as substrate for production of nitric oxides by hepatocytes, reversed the activity of IFN-gamma on these malaria-infected cells. Reversal of IFN-gamma activity by NGMMLA was dose dependent and was maximal at 0.5 mM NGMMLA. Depletion of L-arginine by addition of arginase to the culture medium blocked the capacity of IFN-gamma to inhibit parasite development in hepatocytes; addition of excess L-arginine to cultures treated with IFN-gamma in the presence of NGMMLA competitively restored IFN-gamma capacity to activate hepatocyte anti-parasite activity. TNF-alpha was neither required for IFN-gamma activity, nor effective at any concentration tested as an inhibitor of schizont development by itself in primary hepatocytes. These data strongly suggest that the action of IFN-gamma on P. berghei-infected hepatocytes is to induce the production of L-arginine-derived nitrogen oxides that are toxic for the intracellular parasite.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Arginine / physiology*
  • Cells, Cultured
  • Interferon-gamma / pharmacology*
  • Liver / parasitology*
  • Mice
  • Mice, Inbred BALB C
  • Nitrogen Oxides / metabolism
  • Plasmodium berghei / drug effects*
  • Plasmodium berghei / growth & development
  • Tumor Necrosis Factor-alpha / physiology
  • omega-N-Methylarginine

Substances

  • Nitrogen Oxides
  • Tumor Necrosis Factor-alpha
  • omega-N-Methylarginine
  • Interferon-gamma
  • Arginine